Search research articles
Contact Us
Filters
Showing results (291-300 of 307) with videos related to
Page
of 31
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
December 31, 2003
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial
Adriano Paccagnella, A Favaretto, F Oniga, et al.
The New England Journal of Medicine
|
September 22, 1977
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs
U Veronesi, J Adamus, D C Bandiera, et al.
Tumori
|
June 30, 1980
Stage I melanoma of the limbs. Immediate versus delayed node dissection
U Veronesi, J Adamus, D C Bandiera, et al.
Cancer
|
June 1, 1982
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities
U Veronesi, J Adamus, D C Bandiera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system
C M Balch, S J Soong, J E Gershenwald, et al.
The New England Journal of Medicine
|
October 7, 1982
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma
U Veronesi, J Adamus, C Aubert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2026
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARD
J W Riess, H A Yu, X Le, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F Perrone, F Nuzzo, F Di Rella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
F Nuzzo, C Gallo, S Lastoria, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients
A Puccini, F Grillo, M Fassan, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 307) with videos related to
Sort By:
Page
of 31
Lung Cancer (Amsterdam, Netherlands)
|
December 31, 2003
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial
Adriano Paccagnella, A Favaretto, F Oniga, et al.
The New England Journal of Medicine
|
September 22, 1977
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs
U Veronesi, J Adamus, D C Bandiera, et al.
Tumori
|
June 30, 1980
Stage I melanoma of the limbs. Immediate versus delayed node dissection
U Veronesi, J Adamus, D C Bandiera, et al.
Cancer
|
June 1, 1982
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities
U Veronesi, J Adamus, D C Bandiera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2001
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system
C M Balch, S J Soong, J E Gershenwald, et al.
The New England Journal of Medicine
|
October 7, 1982
A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma
U Veronesi, J Adamus, C Aubert, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2026
Osimertinib plus datopotamab deruxtecan in patients with EGFR-mutated advanced NSCLC post-progression on first-line osimertinib: ORCHARD
J W Riess, H A Yu, X Le, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 10, 2014
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial
F Perrone, F Nuzzo, F Di Rella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2012
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study
F Nuzzo, C Gallo, S Lastoria, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patients
A Puccini, F Grillo, M Fassan, et al.
Page
of 31